We are live on
!
Find out more
iShares US Pharmaceuticals ETF
178 hedge funds and large institutions have $551M invested in iShares US Pharmaceuticals ETF in 2025 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 61 increasing their positions, 26 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
246% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 13
135% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 26
61% more capital invested
Capital invested by funds: $342M → $551M (+$208M)
19% more funds holding
Funds holding: 149 → 178 (+29)
6.65% more ownership
Funds ownership: 58.27% → 64.92% (+6.6%)
Holders
178
Holders Change
+29
Holders Change %
+19.46%
% of All Funds
2.16%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
45
Increased
61
Reduced
26
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
FIA
Foundations Investment Advisors
Phoenix,
Arizona
|
+$51.3M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$26.3M |
| 3 |
Morgan Stanley
New York
|
+$22.7M |
| 4 |
ACM
Anfield Capital Management
Irvine,
California
|
+$9.41M |
| 5 |
JP Morgan Chase
New York
|
+$8.02M |
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$5.02M |
| 2 |
Fisher Asset Management
Camas,
Washington
|
-$4.84M |
| 3 |
Jane Street
New York
|
-$981K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$968K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$592K |